Translational Gap in Glioma Research

Author(s): Chi Ma, Gang Zhao, Mabel Hilda Cruz, Ake Siden, Juan Sebastian Yakisich

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 14 , Issue 8 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


During the last five decades, enormous advances in treatment modalities for cancer and a better understanding of cancer cell biology have been accomplished but the prognosis of patients carrying malignant gliomas still remains poor despite hundreds of clinical trials have been carried out. In this article we review phase II clinical trials that have been completed and published in PubMed during 2011 in order to investigate potential reasons of clinical failure. We suggest that a translational gap, defined as a failure to translate basic research into clinical trials design may explain the poor outcome of phase II clinical trials.

Keywords: Clinical trial, Glioma, phenotype, stem cells, stem cell theory, stemness.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 05 September, 2014
Page: [1110 - 1120]
Pages: 11
DOI: 10.2174/1871520614666140825110907
Price: $65

Article Metrics

PDF: 27